Protocol: Does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myocardial infarction? Nitrites in acute myocardial infarction (NIAMI)

Nishat Siddiqi, Margaret Bruce, Christopher J. Neil, Baljit Jagpal, Graeme Maclennon, Seonaidh C. Cotton, Sofia A. Papadopoulo, Nicholas Bunce, Pitt Lim, Konstantin Schwarz, Satnam Singh, David Hildick-Smith, John D. Horowitz, Melanie Madhani, Nicholas Boon, Juan-Carlos Kaski, Dana Dawson, Michael P. Frenneaux

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)


Whilst advances in reperfusion therapies have reduced early mortality from acute myocardial infarction, heart failure remains a common complication, and may develop very early or long after the acute event. Reperfusion itself leads to further tissue damage, a process described as ischaemia-reperfusion-injury (IRI), which contributes up to 50% of the final infarct size. In experimental models nitrite administration potently protects against IRI in several organs, including the heart. In the current study we investigate whether intravenous sodium nitrite administration immediately prior to percutaneous coronary intervention (PCI) in patients with acute ST segment elevation myocardial infarction will reduce myocardial infarct size. This is a phase II, randomised, placebo-controlled, double-blinded and multicentre trial.
Original languageEnglish
Article number116
JournalJournal of Translational Medicine
Publication statusPublished - 6 May 2013


  • Adolescent
  • Adult
  • Aged
  • Cardiotonic Agents
  • Double-Blind Method
  • Female
  • Great Britain
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Myocardial Infarction
  • Nitric Oxide
  • Percutaneous Coronary Intervention
  • Reperfusion Injury
  • Sodium Nitrite
  • Young Adult

Cite this